Cancer BiologybioRxiv
Multi-omics analysis reveals distinct non-reversion mechanisms of PARPi resistance in BRCA1- versus BRCA2-deficient mammary tumors
DOI 10.1016/j.celrep.2023.112538
Author
M. Paes Dias
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
Biology Disciplines
Click to filter author papersSignature Assays, Organisms & Methods
Click to filter · or open tagActivity by Year
2020-2022 · peak 1/yrCo-Author Collaboration Network
10 top collaborators · 35 mutual co-author linksFocal author (center)Selected co-authorORCID co-authorUnlinked name
Curved chords = mutual co-authorship3 papers
Recent·Most cited
- Cancer BiologybioRxivPreprint
Loss of Nuclear DNA Ligase III Reverts PARP Inhibitor Resistance in BRCA1/53BP1 Double-deficient Cells by Exposing ssDNA Gaps
M. Paes Dias, V. Tripathi, I. v. d. Heijden…·J. Jonkers
This study identifies loss of LIG3 as a factor that reverts PARP inhibitor resistance in BRCA1/53BP1 double-deficient cells by increasing ssDNA gaps.
DOI 10.1101/2021.03.24.436323 - Cell BiologybioRxiv
SMARCAD1 Mediated Active Replication Fork Stability Maintains Genome Integrity
C. Lo, M. van Toorn, V. Gaggioli…·N. Taneja
This study identifies SMARCAD1 as a critical factor for replication fork stability, showing its role in preventing genome instability and enhancing resistance to replication poisons.
DOI 10.1126/sciadv.abe7804